- Nachrichtendetail
-
26.04.2024 14:21:38 - dpa-AFX: *CHMP BACKS J&J'S RYBREVANT COMBO FOR FIRST-LINE NSCLC WITH EGFR EXON 20 MUTATION
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 152,080 | 20.05.24 20:56:45 | -2,560 | -1,66% | 152,080 | 152,090 | 154,860 | 154,640 |
